Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
208 hedge funds and large institutions have $2.85B invested in Ariad Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 21 closing their positions.
62% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 21
34% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 62
6% more capital invested
Capital invested by funds: $2.69B → $2.85B (+$164M)
5% more funds holding
Funds holding: 198 → 208 (+10)
43% less call options, than puts
Call options by funds: $21.9M | Put options by funds: $38.3M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$64.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$34.8M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$31.1M |
| 5 |
Goldman Sachs
New York
|
+$30.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$135M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$62.9M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$55.7M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$44.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$30.1M |
ARIA Hedge Fund Activity: Q3 2013 in Review
208 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2013, worth a combined $2.85B — up 6.1% from $2.69B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ARIA positions and 21 closed out — a net gain of 13 holders — while 83 added to existing stakes and 62 trimmed.
The largest buyer was Franklin Resources, adding an estimated $64.5M. The largest seller was Artisan Partners, cutting an estimated $135M.
- 208 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2013, up from 198 in Q2 2013.
- Funds reported $2.85B of Ariad Pharmaceuticals Inc stock for Q3 2013, up 6.1% quarter-over-quarter.
- 34 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2013 and 21 closed out, a net change of +13 holders.
- The largest Ariad Pharmaceuticals Inc buyer in Q3 2013 was Franklin Resources, an estimated $64.5M added.
- The largest Ariad Pharmaceuticals Inc seller in Q3 2013 was Artisan Partners, an estimated $135M sold.
Based on aggregated 13F filings for Q3 2013.